chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female who on an unspecified date was vaccinated with a second dose of GARDASIL (lot number, injection site and route not reported).  Subsequently the patient's injection arm was paralyzed.  The patient was seeing a neurologist.  The outcome of the patient was unspecified.  Upon internal review, the injection arm paralyzed is determined to be an other important medical events.  No further information is available.
This spontaneous report was received from a medical assistant referring to an unknown number of patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not provided. On unspecified dates, the patients were administered inadvertently doses of PROQUAD subcutaneously, Lot number reported as N000677 with and expiration date on 05-JUL-2018 for prophylaxis (strength and dose were not reported) that had been improperly stored during 1 hour at 10°F. Previously, there was a temperature excursion for 1 hour at 9°F. Concomitantly, the doses of PROQUAD were reconstituted with a properly stored sterile diluent (manufacturer unknown). The call was because of a data logger and no adverse effects were reported. This is one of two cases received from the same reporter.; Sender's Comments: US-009507513-1707USA004356:
IMPROVEMENT IN HIS BRONCHITIS; SORENESS AT INJECTION SITE; This spontaneous report received from a patient concerned a 63 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included bronchitis. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029 expiry: UNKNOWN) dose was not reported, administered on 09-MAR-2021 to left arm  for prophylactic vaccination. No concomitant medications were reported. On 10-MAR-2021, the subject experienced soreness at injection site. On 23-MAR-2021, the subject experienced improvement in his bronchitis. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from soreness at injection site on 11-MAR-2021, and the outcome of improvement in his bronchitis was not reported. This report was non-serious.
3/30/21, Tue. Got up and felt dizzy.  Went to bed a few times to have a sleep. 3/31/21, Wed. Got up and felt better. Went to work but felt no idea of work related material.  4/1/21, Thu.  Got up and felt good, but could not speak too much because of some loss of words. Called for PTO for Thu and Fri.  4/2/21, Fri.  Mindset went back but still could not speak too much. 4/2/21, Fri night.  After bible study at night, almost all bro & sis said that was symptom of stroke, and suggested us to see emergency doctor.  On 11pm, we were at emergency room.  4/3/21, Sat. I was admitted 1-2 am into impatience room. CT diagnosed a big gray area in between speech are and spine. 4/3/21, Sat afternoon. MRI and MRA had been tested.  Cardiologist said he could not rule out the last option, which was due to slow heart beat 50-60. But I have slow heart beat since I remembered things from 4-5 year-old. He suggested wearing a heart monitoring device for a 4 weeks after discharged.  4/4/21, Sun noon.  Doctor admitted to discharge. They could not find cause, and would like to follow up within 1 to 2 weeks after discharging.  4/13/21, Tue night, I started wiring body monitoring device.
Ears clogged, especially the R ear. 9/14/14 - developed nausea, vomiting and vertigo.  Was treated in the ER. Followed up by ENT, diagnosed with R ear hearing loss.
There is a possibility that these COVID doses were given beyond their recommended time of use greater than 12 hours post-puncture.  The dates involved were 9/1/2021, 9/9/2021 and 10/22/2021.  The number of patients impacted is 9.  DOH and CDC have been notified and meetings conducted.  We are following their recommendations to notify and re-vaccinate all patients.  We will enter separate VAERS reports for any individuals experiencing adverse reactions. Root cause identified and processes modified to prevent re-occurrence.
Patient got both vaccines listed above on the same day. Following the next day, the patient started to develop a consistent bout of dizziness which lasted throughout the day for approximately 4 days. Then, the dizziness started to only become problematic when patient was lying down to fall asleep and this is still occurring as of today.
I had the FLUZONE HIGH DOSE shot at 2:00 this afternoon and by 6:00 pm began bronchial cough, fever, headache, swollen tongue, throat, no appetite. It's now 7:00 and I'm hoping this won't last long but I don't know what to expect or how to safely treat these symptoms.
Pt received Hepatitis B 2nd dose on 03/10/2001 0730. He induced a small bump immediately after the injection. The lump has gradually increased in size and pt really noticed the size change in Spetember 2001. Arm is tender and sore to touch. 3 by 3 cm left arm.
severe arm pain Narrative: Patient was seen 3 days after 1stCOVID vaccine at non-Facility hospital because he developed severe pain in ipsilateral scapular area, given Medrol dose pack but still with symptoms. No rashes/swelling. Patient describes pain as shooting pain from shoulder to hand in the same arm as vaccine. Pain began 2 days after vaccine. Pain continued for more than 2 seeks. On 4/1/2021, patient presented for 2nd vaccine. Was discussed with MD who approved 2nd vaccine. Patient noted pain in right arm was getting better. 2nd dose received in opposite arm without pain or redness reported the next day on follow-up.
patient recently suffered another episode of the trigeminal  neuralgia at a severe level; relief from the trigeminal neuralgia after Shingrix first series administration; This non-serious case was reported by a physician via call center representative and described the occurrence of trigeminal neuralgia in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included trigeminal neuralgia. Previously administered products included Shingrix (received 1st dose on Dec-2019).   In MAR-2020, the patient received the 2nd dose of Shingrix. On an unknown date, more than 2 years after receiving Shingrix, the patient experienced trigeminal neuralgia (Verbatim: patient recently suffered another episode of the trigeminal  neuralgia at a severe level) and unexpected therapeutic effect (Verbatim: relief from the trigeminal neuralgia after Shingrix first series administration). The outcome of the trigeminal neuralgia and unexpected therapeutic effect were unknown.   It was unknown if the reporter considered the trigeminal neuralgia to be related to Shingrix.     It was unknown if the company considered the trigeminal neuralgia to be related to Shingrix.   Additional Information: GSK receipt date: 07-NOV-2023 The physician called medical information on behalf his wife (patient). Physician is trying to get his wife to had a second Shingrix series. The patient suffers from trigeminal neuralgia. The physician researched that that zoster virus did stay on the ganglion of the trigeminal nerve.   Last time the patient got the series and relief from the trigeminal neuralgia. The patient recently suffered another episode of the trigeminal neuralgia at a severe level, so they were trying to obtain a second Shingrix series.  Patient's doctor faxed the permission to pharmacy to administer the second Shingrix series, but CVS cooperate office declined. The reporter did not consent to follow up.
some arm soreness; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (some arm soreness) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020L20A) for COVID-19 prophylaxis.     Concurrent medical conditions included Neuromuscular disorder NOS and Bronchiectasis (Bronchiectasis in one of the lobes of her lungs). Concomitant products included BUPROPION HYDROCHLORIDE (BUPROPION XR 150 ADCO), DULOXETINE and AZELASTINE for an unknown indication. On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, the patient experienced PAIN IN EXTREMITY (some arm soreness). At the time of the report, PAIN IN EXTREMITY (some arm soreness) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       Treatment medication was not provided by the reporter.  It was reported that the patient was exposed to Family members who tested positive for Covid-19. The patient had not tested positive for Covid-19 and the patient did not have any Covid-19 Symptoms.
was exposed to Covid, tested postive; was exposed to Covid, tested postive; This is a spontaneous report from a contactable consumer female patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on an unspecified date (Batch/Lot number was not reported) as a single dose for covid-19 immunization. The patient's medical history included exposed to covid-19 on an unknown date. The patient's concomitant medications were not reported. The patient was exposed to covid and was tested positive on an unknown date. It was further reported that patient received the first dose of Covid Vaccine and was due to receive second dose Tuesday. As she was exposed to Covid, tested positive wants to know if she should still get second dose. The outcome of the events was unknown.   Information about lot/batch number has been requested.
This spontaneous report as received from a medical assistant (M.A.) refers to a patient of unknown age and gender. No concurrent condition, medical history or allergy/drug reactions were reported. On 01-OCT-2015, the patient was vaccinated with the third dose of improperly stored oral, ROTATEQ (lot # L000571, expiration date 26-JUL-2016) (dose unspecified). No concomitant medications were reported. No adverse effects have been reported. There were no product quality complaints (PQC) involved. No additional information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
Covid Arm. Redness around injection site. Showed up 10 days after injection.  Lasted a week.
Patient stated a fear of needles but was going to receive shots. Patient received these shots before fainting. Tapped patient until she came to for about a minute or so. No treatment accepted patient waited in pharmacy for an hour. Was given water, cookies, and OJ. Medical attention denied. Call to family/friend denied.
first dose in January 2020, had not yet received second; This case was reported by a consumer via call center representative and described the occurrence of incomplete course of vaccination in a 87-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in January 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced incomplete course of vaccination. On an unknown date, the outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK Receipt Date: 13-MAY-2022 Reporters comment: The patient self-reported the case. She received her first dose of Shingrix in January 2020 and had not yet received her second dose of Shingrix at the time of the call.   The patient did not wish to consent for follow up The patient provided limited information Additional supportive information: Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete vaccination schedule.
She got her vaccine, came home, and seemed to be OK.  Between 6-7 PM she looked at her legs as they were aching and felt like they were getting weak.  When she got up in the middle of the night to use the bathroom they felt weak and heavy and could not get out of bed, no leg strength and her arms were weak too.  The following day she was the same, and could not walk, still had no strength for at least a couple of weeks.   She has been using a walker to get around and was not using prior to the vaccine.  She was having some weakness before the vaccine, but nothing like this, but right after the 2nd shot she was not able to stand on her own, walk, and her husband had to help her in and out of bed.  She is able to walk now without the walker small distances.   She saw her PCP and he did not prescribe anything for her.  He did blood work to test her and nothing came out.  Her rheumatologist also tested her for things and everything was okay and blood work for her heart was good as well.   She has been doing some therapy at home.  Her doctor is also doing some x-rays on her back next week and told them to report the incident as she is still having muscle weakness.   She had some muscle weakness after the first vaccine, but then with the 2nd one it worsened.  She did also have joint pain, fatigue and headaches which went away after 1-2 days.   She is still having the joint pain, but the fatigue is better.
Breakthrough case admission after 3 vaccines Moderna 2/26/21 Lot# 010A21A;  Moderna 3/26/21 Lot# 018B21A;  Moderna 11/2/21 Lot# 077C21B
Received first Gardasil HPV vaccine on 3/19/07, received second vaccine on 5/21/07 by 5/23/07 had a rash on upper arms and shins (front bottom legs), worsened and spread as each week went on. Took Claritin, went to Urgent Care on 6/13/07 received steroid shot in rear and 6 day Predizone pack, rash continued to spread and worsen all over body (arms, legs, stomach, back, butt, hands, neck etc. (not currently on face or feet)- thousands of small bumps, circular patches, hive type bumps (raised and dry) - very itchy and red) went to primary care physican on 6/22/07 told to continue with Claritin during the day and Benedryl at night, also applying Coritizone Cream and Cortaid sent to lab for blood work and urine sample will have results on 6/25/07.
Late period (2 days late) , longer period (3 days longer) heavier period, more painful period. Patients period has been unchanged for 10 years prior to receiving Covid vaccine.
Staff came to a flu clinic at the hospital and stated she would like to have a flu shot. I had her fill out a form. Asked her if she had a flu shot this season. She said no. I provided education and gave her the vaccine. About 10 minutes later she came back to where I was at and told me her friend told her they had already received the flu vaccine in September. Refererred her to her MD for follow up. No s/sx of adverse reaction noted.
Bad headache/like it's inflated whole head. Felt fuzzy-not right. Hives on both arms-terrible itching. These all lasted for 7 days.
About 5 min after getting the first dose, I felt numbness in my left hand.  I was monitored for 60 min and they did blood pressure and oxygen check.  about 10 min in, I felt a little funny in my mouth, like a little bit of swelling, but never to the point of issue with breathing or swallowing.  Numbness seemed to have subsided by the 60 minute time and I went home.  No other symptoms.
pt received 1st dose of Pfizer vaccine on 8/2/2021 in his left arm. 2 days  after his injection  he began having tingling in the contralateral arm (right):  from inside his elbow into his fingertips, intense headache and GI issues  (pebble like stools to formed to loose).  these symptoms have persisted with new  symptom of increased salivation, headache is lessening.  was supposed to get 2nd  vaccine on 8/23/2021 but has not gotten it yet fearing if these symptoms were  from the 1st things would get worse. no prior issues with any prior vaccine.
Nausea, diarrhea, vomiting, fatique, temperature of 100, left work, did not see a doctor
I have and am being treated for psoriatic arthritis. About a month following the initial vaccination my arthritis started to flare-up. Following subsequent vaccinations my condition has been exacerbated. Pain in my ankles, knees and back has steadily increased. My C Reactive P which is an inflammatory marker has been elevated since my my first vaccination. I am a very active individual being a business owner and first responder but have slowed down because of the increased discomfort and pain. On a scale of 1-10, 10 being extremely pain-full, I am now at a steady 6-7.
Individual reports pain at time of injection and return following AM. Individual reports left arm continues to hurt when using it or wt bearing. Denies any redness or swelling at site at site at any time- Physician thought tendon or ligament was inflamed - Rx'd Celebrex but individual refused to take due to concerns re side effects.
Just a few hours after receiving my first Vaccine, I started running a fever of 99.9, Got real sick at my stomach, started have Diarrhea, Severe Headache, My arm hurt really bad could not use it for a Day and 1/2. Just felt like I had been run over by a Bulldozer.
Two days after receiving the vaccine, red rash localized to inner elbows and neck area began. On day 3 after vaccine, a rash started on face and hands and worked its way all over the top half of her body. Patient took Benadryl at home, and then went to the ED, where she received Pepcid and prednisone. The rash went away after 1-2 hours following the medication administration.
My symptoms after the second Moderna COVID-19 Vaccine EUA were as follows; Fatigue, Headache and Nausea.
coughing up phlegm; rhinitis; congestion; constant runny nose; This non-serious case was reported by a consumer via call center representative and described the occurrence of productive cough in a 55-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number DH3A2, expiry date 29-SEP-2025) for prophylaxis.   The patient's past medical history included automobile accident (due to accident patient hospitalized for her injuries).   On 16-MAY-2023, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced productive cough (Verbatim: coughing up phlegm), rhinitis (Verbatim: rhinitis), nasal congestion (Verbatim: congestion) and runny nose (Verbatim: constant runny nose).  The outcome of the productive cough, rhinitis, nasal congestion and runny nose were not resolved.   It was unknown if the reporter considered the productive cough, rhinitis, nasal congestion and runny nose to be related to Boostrix and Boostrix Pre-Filled Syringe Device.     It was unknown if the company considered the productive cough, rhinitis, nasal congestion and runny nose to be related to Boostrix and Boostrix Pre-Filled Syringe Device.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt date: 12-SEP-2023 The patient self-reported this case. The patient was in a roll-over car accident in May 2023, while in the hospital for her injuries, the patient received Boostrix.  Since receiving Boostrix, the patient had experienced coughing up phlegm, rhinitis, constant runny nose, and congestion.  The patient saw an ENT (Ear-Nose-Throat) specialist last month and MRI of the brain was done, lab results suggest there was no leaking from the brain.  The reporter consented to follow up with healthcare professional.
Patient came in on 10/27/23 and spoke with pharmacist on duty. Stated her vaccine(administered 9/27/23 by certified immunizing technician) was given too high on the shoulder. Said vaccination was painful and that day she began experiencing pain in arm, shoulder and scapula. She also has muscle weakness and reduced grip strength. She followed up with PCP on 10/27/23 and was given medrol dosepak to treat symptoms believed to be from vaccine administration.
Shingles rash / on her back, under arm and chest; Shingles rash / on her back, under arm and chest; swelling at the injection site/arm swollen; redness at the injection site/redness; feeling like she had the flu/flu like symptoms; This case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 23rd September 2020, the patient received the 1st dose of Shingrix. On 25th September 2020, 2 days after receiving Shingrix, the patient experienced injection site swelling and injection site erythema. On 26th September 2020, the patient experienced influenza-like symptoms. On 27th September 2020, the patient experienced shingles and rash. On an unknown date, the outcome of the injection site swelling, injection site erythema and influenza-like symptoms were recovered/resolved and the outcome of the shingles and rash were recovering/resolving.   It was unknown if the reporter considered the injection site swelling, injection site erythema, influenza-like symptoms, shingles and rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient experienced swelling and redness at the injection site two days after administration Shingrix that lasted 2 days. 3 days following administration, she reported feeling like she had the flu which lasted 2 days.  4 days after administration, a shingles rash presented on her back, under arm and chest on the left side of her body.  The rash was resolving. The reporter consented to follow up.
9/17/23  Developed lesions on upper extremities 9/18/23  Seen in office - right arm x1, left arm x 5 (small intact vesicles on an 50 cent flat erythematous base, very pruritic) 9/19/23  No new lesions, erythema decreasing in size
Patient was sitting down when he received the vaccination. After about 1 minute he stood up and we were talking. He fainted after he had been standing about 30 seconds. He was on the floor about 5 seconds when he woke up. At that time he was talking and knew who he was , where he was and the people around him.  Paramedics were call and when they arrive it had been about 6 minutes. He was sitting up . Paramedics check his blood pressure and blood sugar. Both were normal. Paramedics sat him in a chair then stood him up.  Patient did not want to  go to the ER. and left with grandmother and brother.
Myopericarditis without effusion or compromised cardiac function, presenting as chest pain, 3 days after Pfizer booster
I got joint and muscle aches. Left armpit lymph nodes swollen for six days. Fatigue for three weeks after vaccine.
Patient was seen on 09/30/22 and was given a Pfizer-BioNTech covid-19 vaccine (6month-4yrs) INSTEAD of Pfizer-BioNTech Covid-19 vaccine (5yrs-11yrs). Incorrect lower dose/vial was given than recommended dose of Pfizer-BioNTech Covid-19. Patient did NOT have a adverse reaction to vaccine.
I woke up this morning in excruciating pain in my left arm. I can barely lift or move it without severe pain shooting down my arm and left side. The pain is getting worse despite taking some Motrin and resting it. I left a message with my PCP to make her aware of it and to get some advice. This is the worst pain I've ever had in my life
Low fever, chills, 24 hrs. Headache Myalgia lasting 48 hrs. Arthralgia lasting 36 hrs.
LUMP AT INJECTION SITE; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received Covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the patient experienced lump at injection site. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of lump at injection site was not reported. This report was non-serious.